Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancer-Reference-Cited by-同舟云学术

Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancer

Published:2007 Issue:10 Volume:67 Page:1029-1037
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Kumagai Jinpei,Fujimura Tetsuya,Takahashi Satoru,Urano Tomohiko,Ogushi Tetsuo,Horie-Inoue Kuniko,Ouchi Yasuyoshi,Kitamura Tadaichi,Muramatsu Masami,Blumberg Bruce,Inoue Satoshi

Publisher

Wiley

Subject

Urology,Oncology

Reference30 articles.

1. Hormones and prostate cancer: Current perspectives and future directions

2. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

3. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

4. The Adrenal Androgen Androstenediol Is Present in Prostate Cancer Tissue after Androgen Deprivation Therapy and Activates Mutated Androgen Receptor

5. Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal obesity impacts fetal liver androgen signalling in a sex-specific manner;Life Sciences;2024-01

2. Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation;International Journal of Molecular Sciences;2021-11-18

3. Osteopontin deficiency leads to the resolution of prostatic fibrosis and inflammation;2021-07-19

4. Altered expression of cytochrome P450 enzymes involved in metabolism of androgens and vitamin D in the prostate as a risk factor for prostate cancer;Pharmacological Reports;2020-07-17

5. Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer;Drug Metabolism and Disposition;2020-06-29